| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | PI | | Travatan | 2.5 ml | 11.02 | 24.95 | 10% | | Augentropfen: Travoprostum 40 µg/ml | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Travatan | 3 x 2.5 ml | 31.44 | 52.50 | 10% | | Augentropfen: Travoprostum 40 µg/ml | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Co-Diovan 160/25 | 28 Tablette(n) | 13.56 | 27.85 | 20% | | Filmtabletten: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Co-Diovan 160/25 | 98 Tablette(n) | 47.42 | 70.85 | 20% | | Filmtabletten: 2 Wirkstoffe | Novartis Pharma Schweiz AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Concor 10 plus | 30 Tablette(n) | 7.55 | 16.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Merck (Schweiz) AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Concor 10 plus | 100 Tablette(n) | 23.56 | 43.45 | 10% | | Filmtabletten: 2 Wirkstoffe | Merck (Schweiz) AG | B / SL / SO | FB | | G |  |
L | | FI | PI | | Revatio | 90 Tablette(n) | 507.84 | 599.40 | 20% | | Filmtabletten: Sildenafilum 20 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Sortis 40 - T | 30 Tablette(n) | 20.05 | 39.40 | 20% | | Filmtabletten: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Sortis 40 - T | 100 Tablette(n) | 65.97 | 92.15 | 20% | | Filmtabletten: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Vascord 20mg/5mg | 28 Tablette(n) | 18.82 | 38.00 | 20% | | Filmtabletten: 2 Wirkstoffe | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Vascord 20mg/5mg | 98 Tablette(n) | 53.74 | 78.10 | 20% | | Filmtabletten: 2 Wirkstoffe | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Vascord 40mg/10mg | 28 Tablette(n) | 24.27 | 44.25 | 20% | | Filmtabletten: 2 Wirkstoffe | A. Menarini GmbH | B / SL / SO | FB | | G |  |
L | | FI | PI | | Vascord 40mg/10mg | 98 Tablette(n) | 73.48 | 100.75 | 20% | | Filmtabletten: 2 Wirkstoffe | A. Menarini GmbH | B / SL / SO | FB | | G |  |
| KFI | FI | PI | | Lyrica 25 mg - T | 14 Kapsel(n) | 5.79 | 14.85 | 20% | | Kapseln: Pregabalinum 25 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| KFI | FI | PI | | Lyrica 25 mg - T | 56 Kapsel(n) | 16.37 | 35.20 | 20% | | Kapseln: Pregabalinum 25 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| KFI | FI | PI | | Lyrica 300 mg | 56 Kapsel(n) | 53.88 | 78.25 | 20% | | Kapseln: Pregabalinum 300 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| KFI | FI | PI | | Lyrica 300 mg | 168 Kapsel(n) | 158.41 | 198.25 | 20% | | Kapseln: Pregabalinum 300 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Neurontin 300 mg | 50 Kapsel(n) | 21.23 | 40.75 | 20% | | Kapseln: Gabapentinum 300 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Neurontin 300 mg | 100 Kapsel(n) | 41.68 | 64.25 | 20% | | Kapseln: Gabapentinum 300 mg | Viatris Pharma GmbH | B / SL / SO | FB | | G |  |
| | FI | PI | | Trittico 50 mg - T | 30 Tablette(n) | 9.60 | 19.20 | 10% | | Tabletten: Trazodoni Hydrochloridum 50 mg | OM Pharma Suisse SA | B / SL / SO | FB | | G |  |
| | FI | PI | | Trittico 50 mg - T | 100 Tablette(n) | 27.26 | 47.65 | 10% | | Tabletten: Trazodoni Hydrochloridum 50 mg | OM Pharma Suisse SA | B / SL / SO | FB | | G |  |
| | FI | | | Cytosar Solution 100 mg/5 ml | Durchstechflasche(n) | 3.57 | 8.20 | 10% | | Injektionslöung: Cytarabinum 100mg / 5ml | Pfizer AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Travoprost-Mepha Plus 0.04mg/5mg | 2.5 ml | 13.46 | 27.75 | 10% | | Augentropfen: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
| | FI | PI | | Travoprost-Mepha Plus 0.04mg/5mg | 3 x 2.5 ml | 38.36 | 60.45 | 10% | | Augentropfen: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | CM | Zoledronat Osteo Sandoz 5 mg/100 ml | Durchstechflasche(n) | 214.03 | 262.10 | 10% | | Infusionslösung: Acidum Zoledronicum 5mg / 100ml | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Ecomucyl Sandoz 600 | 10 Sachet(s) | 3.14 | 5.80 | 10% | | Granulat: Acetylcysteinum 600 mg | Sandoz Pharmaceuticals AG | ● D / SL / SG | FB | | G |  |
L | | FI | PI | | Ecomucyl Sandoz 600 | 100 Sachet(s) | 18.40 | 37.50 | 10% | | Granulat: Acetylcysteinum 600 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Aripiprazol NOBEL 1 mg/ml | 150 ml | 90.07 | 119.80 | 10% | | Sirup: Aripiprazolum 1 mg/ml | NOBEL Pharma Schweiz AG | B / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Mylan 100 mg | | 224.25 | 273.85 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Mylan Pharma GmbH | A / SL / SG | FB | | G |  |
| | FI | PI | | Valproat Sandoz 300 mg | 100 Tablette(n) | 9.98 | 19.65 | 10% | | Retard-Tabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Valproat Sandoz 500 mg | 60 Tablette(n) | 10.75 | 20.55 | 10% | | Retard-Tabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Atorvastatin Viatris 40 mg | 30 | 13.03 | 27.25 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
L | | FI | PI | CM | Atorvastatin Viatris 40 mg | 100 | 42.88 | 65.65 | 10% | | Filmtabletten: Atorvastatinum 40 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | | Citalopram Sandoz 20 ‐ F - T | 28 Tablette(n) | 12.53 | 26.70 | 10% | | Filmtabletten: Citalopramum 20 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Citalopram Sandoz 20 ‐ F - T | 98 Tablette(n) | 45.84 | 69.00 | 10% | | Filmtabletten: Citalopramum 20 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Citalopram Sandoz 40 - T | 28 Tablette(n) | 30.24 | 51.10 | 10% | | Filmtabletten: Citalopramum 40 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
| | FI | PI | | Citalopram Sandoz 40 - T | 98 Tablette(n) | 85.12 | 114.10 | 10% | | Filmtabletten: Citalopramum 40 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 80/12.5 | 28 Tablette(n) | 9.71 | 19.35 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 80/12.5 | 98 Tablette(n) | 31.40 | 52.45 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/12.5 | 28 Tablette(n) | 11.53 | 25.55 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/12.5 | 98 Tablette(n) | 40.31 | 62.70 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/25 | 28 Tablette(n) | 11.53 | 25.55 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Co-Valsartan Sandoz 160/25 | 98 Tablette(n) | 40.31 | 62.70 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Irbesartan HCT Zentiva 150/12.5 mg | 28 Tablette(n) | 9.29 | 18.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Irbesartan HCT Zentiva 150/12.5 mg | 98 Tablette(n) | 29.99 | 50.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Irbesartan HCT Zentiva 300/25 mg | 28 Tablette(n) | 12.70 | 26.90 | 10% | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Irbesartan HCT Zentiva 300/25 mg | 98 Tablette(n) | 43.85 | 66.75 | 10% | | Filmtabletten: 2 Wirkstoffe | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | | | Perindopril Zentiva 10 mg | 30 | 11.58 | 25.60 | 10% | | Filmtabletten: Perindoprilum Argininum 10 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | | | Perindopril Zentiva 10 mg | 90 | 22.68 | 42.45 | 10% | | Filmtabletten: Perindoprilum Argininum 10 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Perindopril-Indapamid- Mepha 2.5 mg/0.625 mg | 30 Tablette(n) | 9.46 | 19.05 | 10% | | Filmtabletten: 2 Wirkstoffe | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Perindopril-Indapamid- Mepha 2.5 mg/0.625 mg | 90 Tablette(n) | 24.10 | 44.05 | 10% | | Filmtabletten: 2 Wirkstoffe | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | | | Sitagliptin Sandoz eco 50 mg | 28 | 18.61 | 37.75 | 10% | | Filmtabletten: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | | | Sitagliptin Sandoz eco 50 mg | 98 | 65.13 | 91.15 | 10% | | Filmtabletten: Sitagliptinum 50 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Tenofovir-Mepha | 30 Tablette(n) | 227.81 | 277.95 | 10% | | Filmtabletten: Tenofovirum Disoproxilum 245 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | PI | CM | Gabapentin Pfizer 100 mg | 50 Kapsel(n) | 7.69 | 17.00 | 10% | | Kapseln: Gabapentinum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Gabapentin Pfizer 100 mg | 100 Kapsel(n) | 13.53 | 27.80 | 10% | | Kapseln: Gabapentinum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Pregabalin Viatris 50 mg | 14 | 3.89 | 8.55 | 10% | | Kapseln: Pregabalinum 50 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Pregabalin Viatris 50 mg | 84 | 20.53 | 39.95 | 10% | | Kapseln: Pregabalinum 50 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | CM | Pregabalin Viatris 100 mg | 84 | 23.37 | 43.25 | 10% | | Kapseln: Pregabalinum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | FI | PI | | Candesartan Spirig HC 16 mg | 30 | 8.73 | 18.20 | 10% | | Tabletten: Candesartanum Cilexetilum 16 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Candesartan Spirig HC 16 mg | 100 | 29.38 | 50.15 | 10% | | Tabletten: Candesartanum Cilexetilum 16 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Ezetimib-Simvastatin- Mepha 10 mg / 10 mg | 28 | 12.62 | 26.80 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | PI | | Ezetimib-Simvastatin- Mepha 10 mg / 10 mg | 98 | 44.04 | 66.95 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 20 mg | 28 | 14.22 | 28.60 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 20 mg | 98 | 49.63 | 73.40 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 40 mg | 28 | 16.56 | 35.40 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 40 mg | 98 | 57.17 | 82.05 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 80 mg | 28 | 20.06 | 39.45 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | | | Ezetimib-Simvastatin- Mepha 10 mg / 80 mg | 98 | 70.16 | 96.95 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | ● B / SL / SG | FB | | G |  |
L | | FI | PI | | Glimeryl-Mepha 2 mg | 30 Tablette(n) | 4.46 | 9.20 | 10% | | Tabletten: Glimepiridum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Glimeryl-Mepha 2 mg | 120 Tablette(n) | 14.54 | 29.00 | 10% | | Tabletten: Glimepiridum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Glimeryl-Mepha 4 mg | 30 Tablette(n) | 7.47 | 16.80 | 10% | | Tabletten: Glimepiridum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Glimeryl-Mepha 4 mg | 120 Tablette(n) | 25.36 | 45.50 | 10% | | Tabletten: Glimepiridum 4 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Telmisartan-HCT-Mepha 80/12.5 mg | 28 Tablette(n) | 13.25 | 27.50 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Telmisartan-HCT-Mepha 80/12.5 mg | 98 Tablette(n) | 46.00 | 69.20 | 10% | | Tabletten: 2 Wirkstoffe | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Zolmitriptan Spirig HC 2.5 | 3 Tablette(n) | 10.14 | 19.85 | 10% | | Tabletten: Zolmitriptanum 2.5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Zolmitriptan Spirig HC 2.5 | 6 Tablette(n) | 19.40 | 38.65 | 10% | | Tabletten: Zolmitriptanum 2.5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Zolmitriptan Spirig HC 2.5 | 12 Tablette(n) | 34.04 | 55.50 | 10% | | Tabletten: Zolmitriptanum 2.5 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Alendron-Mepha 70 mg | 4 Tablette(n) | 17.19 | 36.15 | 10% | | Filmtablette: Acidum Alendronicum 70 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Alendron-Mepha 70 mg | 12 Tablette(n) | 49.55 | 73.30 | 10% | | Filmtablette: Acidum Alendronicum 70 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Ecomucyl Sandoz 100 | 30 Sachet(s) | 1.83 | 3.40 | 10% | | Granulat mit Orangen-Aroma: Acetylcysteinum 100 mg | Sandoz Pharmaceuticals AG | D / SL / SG | FB | | G |  |
| | FI | PI | | Ecomucyl Sandoz 200 | 30 Sachet(s) | 3.14 | 5.80 | 10% | | Granulat mit Orangen-Aroma: Acetylcysteinum 200 mg | Sandoz Pharmaceuticals AG | ● D / SL / SG | FB | | G |  |
| | FI | PI | | Ecomucyl Sandoz 200 | 100 Sachet(s) | 6.14 | 15.25 | 10% | | Granulat mit Orangen-Aroma: Acetylcysteinum 200 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | | G |  |
L | | FI | PI | | Symdeko 100 mg / 150 mg und 150 mg | 56 | 12896.42 | 13464.85 | 10% | | | Vertex Pharmaceuticals (CH) GmbH | A / SL | FB | | G |  |
| | FI | | | Haldol Decanoas 50 mg/mL | Ampulle(n) à 1 ml | 5.69 | 14.75 | 10% | | Injektionslösung: Haloperidolum 50 mg/ml | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Imlygic 10e8 | Durchstechflasche(n) à 1 ml | 2229.44 | 2506.65 | 10% | | Injektionslösung: Talimogenum Laherparepvecum 100 | Amgen Switzerland AG | A / SL | FB | | G |  |
L | | FI | PI | PS | Stelara 45 mg | | 3074.64 | 3397.50 | 10% | | Injektionslösung: Ustekinumabum 45mg / 0.5ml | Janssen-Cilag AG | B / SL | FB | | G |  |
| | FI | PI | | Avonex | Set(s) | 942.59 | 1095.30 | 10% | | Injektionslösung in Fertigspritze: Interferonum Beta-1a Adnr 30 µg | Biogen Switzerland AG | B / SL | FB | | G |  |
L | | FI | | | Binocrit 4000 IE/0,4 ml | 6 x 0.4 ml | 172.74 | 214.70 | 10% | | Injektionslösung in Fertigspritze: Epoetinum Alfa 4000U.I. / 0.4ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G |  |
L | | FI | PI | | Erelzi 50 mg/1 ml | 2 | 426.38 | 505.90 | 10% | | Injektionslösung in Fertigspritze: Etanerceptum 50 mg/ml | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
L | | FI | PI | | Erelzi 25 mg/0.5 ml | 4 | 435.08 | 515.85 | 10% | | Injektionslösung in Fertigspritze: Etanerceptum 25mg / 0.5ml | Sandoz Pharmaceuticals AG | B / SL | FB | | G |  |
| | FI | | | Monofer 1000 mg / 10 ml | 10 ml | 268.66 | 324.80 | 10% | | Lösung zur intravenösen Injektion/Infusion: Ferrum(iii) 1000 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | FI | | | Monofer 1000 mg / 10 ml | 2 x 10 ml | 537.33 | 633.25 | 10% | | Lösung zur intravenösen Injektion/Infusion: Ferrum(iii) 1000 mg | Pierre Fabre Pharma SA | B / SL | FB | | G |  |
| | FI | | | Ilomedin 50 i.v. | Ampulle(n) à 2.5 ml | 68.27 | 94.75 | 10% | | Infusionskonzentrat: Iloprostum 50µg / 2.5ml | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | | | Imfinzi 120 mg/2.4 ml | | 574.06 | 675.40 | 10% | | Infusionskonzentrat: Durvalumabum 120mg / 2.4ml | AstraZeneca AG | A / SL | FB | | G |  |
L | | FI | | | Imfinzi 500 mg/10 ml | | 2391.91 | 2684.85 | 10% | | Infusionskonzentrat: Durvalumabum 500mg / 10ml | AstraZeneca AG | A / SL | FB | | G |  |
L | | FI | | | Keytruda 100 mg/4 ml | 2 | 4407.68 | 4763.85 | 10% | | Infusionskonzentrat: Pembrolizumabum 100mg / 4ml | MSD Merck Sharp & Dohme AG | A / SL | FB | | G |  |
L | | FI | | PS | Adcetris | Durchstechflasche(n) | 3358.75 | 3688.70 | 10% | | Lyophilisat: Brentuximabum Vedotinum 50 mg | Takeda Pharma AG | A / SL | FB | | G |  |
L | | FI | | PS | Adcetris | 2 Durchstechflasche(n) | 6717.49 | 7131.45 | 10% | | Lyophilisat: Brentuximabum Vedotinum 50 mg | Takeda Pharma AG | A / SL | FB | | G |  |
| | FI | PI | | Minitran 5 | 30 Pflaster | 13.70 | 28.05 | 10% | | Transdermales Pflaster: Glyceroli Trinitras 18 mg | MEDA Pharma GmbH | B / SL | FB | | G |  |
| | FI | PI | | Minitran 10 | 30 Pflaster | 18.06 | 37.15 | 10% | | Transdermales Pflaster: Glyceroli Trinitras 36 mg | MEDA Pharma GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 1 mg | 7 | 17.74 | 36.75 | 10% | | Retard-Tabletten: Guanfacinum 1 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 1 mg | 28 | 70.92 | 97.80 | 10% | | Retard-Tabletten: Guanfacinum 1 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 2 mg | 7 | 18.10 | 37.20 | 10% | | Retard-Tabletten: Guanfacinum 2 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 2 mg | 28 | 72.41 | 99.55 | 10% | | Retard-Tabletten: Guanfacinum 2 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 3 mg | 28 | 75.76 | 103.35 | 10% | | Retard-Tabletten: Guanfacinum 3 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Intuniv 4 mg | 28 | 81.66 | 110.15 | 10% | | Retard-Tabletten: Guanfacinum 4 mg | Takeda Pharma AG | B / SL | FB | | G |  |
L | | FI | PI | | Ranexa 500 mg | 60 Tablette(n) | 51.11 | 75.05 | 10% | | Retard-Tabletten: Ranolazinum 500 mg | A. Menarini GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Ranexa 500 mg | 100 Tablette(n) | 83.59 | 112.35 | 10% | | Retard-Tabletten: Ranolazinum 500 mg | A. Menarini GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Erleada 60 mg | 4 x 28 | 3006.28 | 3327.45 | 10% | | Filmtabletten: Apalutamidum 60 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Invokana 100 mg | 30 Tablette(n) | 44.03 | 66.95 | 10% | | Filmtabletten: Canagliflozinum 100 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Invokana 100 mg | 100 Tablette(n) | 146.77 | 184.90 | 10% | | Filmtabletten: Canagliflozinum 100 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Invokana 300 mg | 30 Tablette(n) | 63.41 | 89.20 | 10% | | Filmtabletten: Canagliflozinum 300 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | PS | Invokana 300 mg | 100 Tablette(n) | 211.35 | 259.05 | 10% | | Filmtabletten: Canagliflozinum 300 mg | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Mayzent 0.25 mg | 12 | 251.62 | 305.25 | 10% | | Filmtabletten: Siponimodum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
L | | FI | PI | | Mayzent 0.25 mg | 120 | 1509.70 | 1717.25 | 10% | | Filmtabletten: Siponimodum | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
L | | FI | | | Mayzent 2.00 mg | 28 | 1409.05 | 1606.90 | 10% | | Filmtabletten: Siponimodum 2 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | FI | PI | | Myambutol 100mg | 100 Tablette(n) | 20.39 | 39.80 | 10% | | Filmtabletten: Ethambutoli Hydrochloridum 100 mg | Labatec Pharma SA | B / SL | FB | | G |  |
| | FI | PI | | Myambutol 400mg | 100 Tablette(n) | 68.78 | 95.35 | 10% | | Filmtabletten: Ethambutoli Hydrochloridum 400 mg | Labatec Pharma SA | ● B / SL | FB | | G |  |
| | FI | PI | | Nozinan 25 mg | 20 | 2.44 | 6.90 | 10% | | Filmtabletten: Levomepromazinum 25 mg | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G |  |
| | FI | PI | | Nozinan 25 mg | 100 | 10.72 | 20.50 | 10% | | Filmtabletten: Levomepromazinum 25 mg | Sanofi-Aventis (Suisse) SA | ● B / SL | FB | | G |  |
L | | FI | PI | PS | Olumiant 2 mg | 28 | 909.27 | 1058.75 | 10% | | Filmtabletten: Baricitinibum 2 mg | Eli Lilly (Suisse) SA | B / SL | FB | | G |  |
L | | FI | PI | PS | Olumiant 4 mg | 28 | 909.27 | 1058.75 | 10% | | Filmtabletten: Baricitinibum 4 mg | Eli Lilly (Suisse) SA | B / SL | FB | | G |  |
| | FI | | | Saroten 25 mg | 50 | 3.48 | 8.10 | 10% | | Filmtabletten: Amitriptylinum 25 mg | Lundbeck (Schweiz) AG | B / SL | FB | | G |  |
| | FI | | | Saroten 25 mg | 100 | 6.12 | 15.25 | 10% | | Filmtabletten: Amitriptylinum 25 mg | Lundbeck (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 50 mg / 850 mg | 60 Tablette(n) | 45.06 | 68.15 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 50 mg / 850 mg | 180 Tablette(n) | 131.06 | 166.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 150 mg / 850 mg | 60 Tablette(n) | 66.08 | 92.25 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 150 mg / 850 mg | 180 Tablette(n) | 198.23 | 243.95 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 50 mg / 1000 mg | 60 Tablette(n) | 45.06 | 68.15 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 50 mg / 1000 mg | 180 Tablette(n) | 131.06 | 166.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 150 mg / 1000 mg | 60 Tablette(n) | 66.08 | 92.25 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Vokanamet 150 mg / 1000 mg | 180 Tablette(n) | 198.23 | 243.95 | 10% | | Filmtabletten: 2 Wirkstoffe | Janssen-Cilag AG | B / SL | FB | | G |  |
L | | FI | PI | | Xarelto vascular 2,5 mg | 56 | 56.43 | 81.20 | 10% | | Filmtabletten: Rivaroxabanum 2.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | | Xarelto vascular 2,5 mg | 196 | 197.51 | 243.15 | 10% | | Filmtabletten: Rivaroxabanum 2.5 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
L | | FI | PI | | Tafinlar 75 mg | 28 Kapsel(n) | 1230.27 | 1410.80 | 10% | | Kapseln: Dabrafenibum 75 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
L | | FI | PI | | Tafinlar 75 mg | 120 Kapsel(n) | 5272.59 | 5650.40 | 10% | | Kapseln: Dabrafenibum 75 mg | Novartis Pharma Schweiz AG | A / SL | FB | | G |  |
| | FI | PI | | Micardis Amlo 80/10 mg | 28 Tablette(n) | 23.98 | 43.95 | 10% | | Tabletten: 2 Wirkstoffe | Boehringer Ingelheim (Schweiz) GmbH | ● B / SL | FB | | G |  |
| | FI | PI | | Micardis Amlo 80/10 mg | 98 Tablette(n) | 71.35 | 98.30 | 10% | | Tabletten: 2 Wirkstoffe | Boehringer Ingelheim (Schweiz) GmbH | B / SL | FB | | G |  |
L | | FI | PI | | Pemazyre 4,5 mg | 14 | 7907.33 | 8351.00 | 10% | | Tabletten: Pemigatinibum 4.5 mg | Incyte Biosciences International Sàrl | A / SL | FB | | G |  |
L | | FI | | | Pemazyre 9 mg | 14 | 7907.33 | 8351.00 | 10% | | Tabletten: Pemigatinibum 9 mg | Incyte Biosciences International Sàrl | A / SL | FB | | G |  |
L | | FI | | | Pemazyre 13,5 mg | 14 | 7907.33 | 8351.00 | 10% | | Tabletten: Pemigatinibum 13.5 mg | Incyte Biosciences International Sàrl | A / SL | FB | | G |  |
L | | FI | PI | BM | Actiq 400 Mikrogramm | 3 Tablette(n) | 24.86 | 44.95 | 10% | | Buccaltabletten: Fentanylum 400 µg | Teva Pharma AG | A+ / SL | FB | | G |  |
L | | FI | PI | BM | Actiq 400 Mikrogramm | 30 Tablette(n) | 236.11 | 287.45 | 10% | | Buccaltabletten: Fentanylum 400 µg | Teva Pharma AG | A+ / SL | FB | | G |  |
L | | FI | | PS | Herceptin subkutan 600mg/5ml | | 1706.26 | 1932.85 | 10% | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | FI | | | Veklury | | 444.46 | 526.65 | 10% | | Pulver für Konzentrat zur Herstellung einer Infusionslösung: Remdesivirum 100 mg | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
L | | FI | | | Mycamine 50 mg | Durchstechflasche(n) | 253.58 | 307.50 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Micafunginum 50 mg | Astellas Pharma AG | A / SL | FB | | G |  |
L | | FI | | | Mycamine 100 mg | Durchstechflasche(n) | 424.35 | 503.55 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Micafunginum 100 mg | Astellas Pharma AG | A / SL | FB | | G |  |
L | | FI | | | Ogivri 150 mg | | 475.67 | 562.45 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Mylan Pharma GmbH | A / SL | FB | | G |  |
L | | FI | | | Padcev 20 mg | | 681.24 | 798.45 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 20 mg | Astellas Pharma AG | A / SL | FB | | G |  |
L | | FI | | | Padcev 30 mg | | 1028.09 | 1189.05 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Enfortumabum Vedotinum 30 mg | Astellas Pharma AG | A / SL | FB | | G |  |
L | | FI | PI | I/B | Cinryze 500 U | | 1382.03 | 1457.60 | 10% | | Pulver und Lösungsmittel: Proteina Plasmatis Humani | Takeda Pharma AG | B / SL | FB | | G |  |
| | FI | | | Envarsus 1 mg | 30 | 119.70 | 153.80 | 10% | | comprimés à libération prolongée: Tacrolimusum 1 mg | Chiesi SA | A / SL | FB | | G |  |
| | FI | PI | | Blissel | 30 g | 21.43 | 41.00 | 10% | | gel vaginale: Estriolum | Effik SA | B / SL | FB | | G |  |
| | FI | PI | | Blissel | 30 g | 21.43 | 41.00 | 10% | | gel vaginale: Estriolum | Effik SA | B / SL | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 0.5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 0.5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 0.5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 10 x 0.5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 10 x 0.5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Adacel-Polio 0.5 ml | 10 x 5 ml | PA | PA | k.A. | | | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | Boostrix Polio | Spritze(n) à 0.5 ml | 26.91 | 47.30 | k.A. | | 4 Wirkstoffe | GlaxoSmithKline AG | ● B | FB | | G |  |
| | FI | | I/B | Boostrix Polio | 10 x 0.5 ml | PA | PA | k.A. | | 4 Wirkstoffe | GlaxoSmithKline AG | B | FB | | G |  |
| | FI | | | Symdeko 50 mg / 75 mg und 75 mg | 56 | PA | PA | k.A. | | | Vertex Pharmaceuticals (CH) GmbH | A | FB | | G |  |
| | FI | PI | | Yescarta | 68 ml | PA | PA | k.A. | | Axicabtagenum Ciloleucelum Zelldispersion von 0.4 – 2 X 10e8 Zellen/einzel-Infusionsbeutel (68 Ml) | Gilead Sciences Switzerland Sàrl | A | FB | | G |  |
| | FI | | | Abrilada 40 mg / 0.8 ml | 2 | PA | PA | k.A. | | Injektionslösung: Adalimumabum 40mg / 0.8ml | Pfizer AG | B | FB | | G |  |
| | FI | | PS | Briviact 50 mg/5 ml | 10 | PA | PA | k.A. | | Injektionslösung: Brivaracetamum 50 mg | UCB-Pharma SA | B | FB | | G |  |
| | FI | | | Evusheld | 2 | PA | PA | k.A. | | Injektionslösung: Tixagevimabum 150mg / 1.5ml Injektionslösung: Cilgavimabum 150mg / 1.5ml | AstraZeneca AG | A | FB | | G |  |
| | FI | PI | | Erelzi 25 mg/0.5 ml | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 25mg / 0.5ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | | | Erelzi 50 mg/1 ml | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 50 mg/ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Erelzi 25 mg/0.5 ml | 2 | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 25mg / 0.5ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | | | Erelzi 50 mg/1 ml | 4 | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 50 mg/ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Erelzi 25 mg/0.5 ml | 12 | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 25mg / 0.5ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | | | Erelzi 50 mg/1 ml | 12 | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Etanerceptum 50 mg/ml | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | FI | PI | | Dafalgan Direct 250 mg (Erdbeer) | 16 | PA | PA | k.A. | | Granulat: Paracetamolum 250 mg | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Dafalgan Direct 500 mg (Rote Beeren) | 16 | PA | PA | k.A. | | Granulat: Paracetamolum 500 mg | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Dafalgan Direct 500 mg (Grapefruit) | 16 | PA | PA | k.A. | | Granulat: Paracetamolum 500 mg | UPSA Switzerland AG | D | FB | | G |  |
| | FI | | | Dafalgan Direct 1000 mg (Rote Beeren) | 16 | PA | PA | k.A. | | Granulat: Paracetamolum 1000 mg | UPSA Switzerland AG | B | FB | | G |  |
| | FI | | | Sidovis | | PA | PA | k.A. | | Infusionskonzentrat: Cidofovirum 75 mg/ml | Ideogen AG | A | FB | | G |  |
| | FI | | | Xevudy | | PA | PA | k.A. | | Infusionskonzentrat: Sotrovimabum 500mg / 8ml | GlaxoSmithKline AG | A | FB | | G |  |
| | FI | | | Imipenem-Cilastatin Labatec | 10 x 500 mg | PA | PA | k.A. | | Trockensubstanz: 2 Wirkstoffe | Labatec Pharma SA | A | FB | | G |  |
| | FI | | | Intuniv 2 mg | 84 | PA | PA | k.A. | | Retard-Tabletten: Guanfacinum 2 mg | Takeda Pharma AG | B | FB | | G |  |
| | FI | | | Intuniv 3 mg | 84 | PA | PA | k.A. | | Retard-Tabletten: Guanfacinum 3 mg | Takeda Pharma AG | B | FB | | G |  |
| | FI | | | Intuniv 4 mg | 84 | PA | PA | k.A. | | Retard-Tabletten: Guanfacinum 4 mg | Takeda Pharma AG | B | FB | | G |  |
| | FI | PI | | Ranexa 500 mg | 30 Tablette(n) | PA | PA | k.A. | | Retard-Tabletten: Ranolazinum 500 mg | A. Menarini GmbH | B | FB | | G |  |
| | FI | PI | CM | Minerva | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Minerva | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | PS | Inovelon 100 mg | 10 Tablette(n) | 11.74 | 25.75 | k.A. | | Filmtabletten: Rufinamidum 100 mg | Eisai Pharma AG | B | FB | | G |  |
| | FI | PI | | Myambutol 100mg | 100 Tablette(n) | 16.99 | 35.90 | k.A. | | Filmtabletten: Ethambutoli Hydrochloridum 100 mg | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Tenofovir-Mepha | 90 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Tenofovirum Disoproxilum 245 mg | Mepha Pharma AG | A | FB | | G |  |
| | FI | PI | | Xarelto vascular 2,5 mg | 10 x 1 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Xarelto vascular 2,5 mg | 30 x 1 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Xarelto vascular 2,5 mg | 100 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Calobalin Sandoz 60 | 42 Kapsel(n) | PA | PA | k.A. | | Kapseln: Orlistatum 60 mg | Sandoz Pharmaceuticals AG | D / LPPV | FB | | G |  |
| | FI | PI | | Calobalin Sandoz 60 | 84 Kapsel(n) | PA | PA | k.A. | | Kapseln: Orlistatum 60 mg | Sandoz Pharmaceuticals AG | D | FB | | G |  |
| | FI | PI | | Calobalin Sandoz 60 ‐ F | 126 Kapsel(n) | PA | PA | k.A. | | Kapseln: Orlistatum 60 mg | Sandoz Pharmaceuticals AG | D / LPPV | FB | | G |  |
| | FI | PI | CM | Celecoxib Viatris 100 mg | 30 | PA | PA | k.A. | | Kapseln: Celecoxibum 100 mg | Viatris Pharma GmbH | B | FB | | G |  |
| | FI | PI | CM | Celecoxib Viatris 200 mg | 30 | PA | PA | k.A. | | Kapseln: Celecoxibum 200 mg | Viatris Pharma GmbH | B | FB | | G |  |
| | FI | PI | CM | Celecoxib Viatris 200 mg | 100 | PA | PA | k.A. | | Kapseln: Celecoxibum 200 mg | Viatris Pharma GmbH | B | FB | | G |  |
| | FI | PI | | Ephynal | 100 Kapsel(n) | PA | PA | k.A. | | Kapseln: Int-Rac-Alpha-Tocopherylis Acetas 300 mg | Bayer (Schweiz) AG | D | FB | | G |  |
| | FI | PI | | Candesartan Spirig HC 16 mg | 28 | 8.15 | 17.55 | k.A. | | Tabletten: Candesartanum Cilexetilum 16 mg | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Candesartan Spirig HC 16 mg | 98 | 28.80 | 49.45 | k.A. | | Tabletten: Candesartanum Cilexetilum 16 mg | Spirig HealthCare AG | B | FB | | G |  |
| | FI | | | Isoniaz-TB 300 mg | 30 | PA | PA | k.A. | | Tabletten: Isoniazidum 300 mg | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Pemazyre 4,5 mg | 28 | PA | PA | k.A. | | Tabletten: Pemigatinibum 4.5 mg | Incyte Biosciences International Sàrl | A | FB | | G |  |
| | FI | | | Pemazyre 9 mg | 28 | PA | PA | k.A. | | Tabletten: Pemigatinibum 9 mg | Incyte Biosciences International Sàrl | A | FB | | G |  |
| | FI | | | Pemazyre 13,5 mg | 28 | PA | PA | k.A. | | Tabletten: Pemigatinibum 13.5 mg | Incyte Biosciences International Sàrl | A | FB | | G |  |
| | FI | PI | | Optifen Dolo Liquid Caps 400 mg | 10 | PA | PA | k.A. | | Weichkapseln: Ibuprofenum 400 mg | Spirig HealthCare AG | D | FB | | G |  |
| | FI | PI | | Opticrom-Allergo | 20 x 0.3 ml | PA | PA | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Opella Healthcare Switzerland AG | D | FB | | G |  |
| | FI | PI | | Opticrom-Allergo | 40 x 0.3 ml | PA | PA | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Opella Healthcare Switzerland AG | D | FB | | G |  |
| | FI | | | REKAMBYS 600 mg / 2 ml | | PA | PA | k.A. | | Depot-Injektionssuspension: Rilpivirinum 600mg / 2ml | Janssen-Cilag AG | A | FB | | G |  |
| | FI | | | Amikacin Ideogen 1 g/4 ml | | PA | PA | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum | Ideogen AG | A | FB | | G |  |
| | FI | | | Amikacin Ideogen 1 g/4 ml | 5 | PA | PA | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum | Ideogen AG | A | FB | | G |  |
| | FI | PI | | Blissel | 10 g | 12.20 | 26.30 | k.A. | | gel vaginale: Estriolum | Effik SA | B | FB | | G |  |
| | FI | PI | | Blissel | 10 g | 12.20 | 26.30 | k.A. | | gel vaginale: Estriolum | Effik SA | B | FB | | G |  |
| | FI | | | Idefirix 11 mg | | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg | iQone Healthcare Switzerland SA | A | FB | | G |  |
| | FI | | | Idefirix 11 mg | 2 | PA | PA | k.A. | | poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg | iQone Healthcare Switzerland SA | A | FB | | G |  |
| | FI | | | Corotrop | 10 1 Ampulle(n) à 10 ml | PA | 620.05 | k.A. | | solution injectable / pour perfusion: Milrinonum 1 mg/ml | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Mounjaro 2.5 mg | 4 | PA | PA | k.A. | | solution pour injection en stylo pré-rempli: Tirzepatidum 2.5mg / 0.5ml | Eli Lilly (Suisse) SA | B | FB | | G |  |
| | FI | | | Mounjaro 7.5 mg | 4 | PA | PA | k.A. | | solution pour injection en stylo pré-rempli: Tirzepatidum 7.5mg / 0.5ml | Eli Lilly (Suisse) SA | B | FB | | G |  |
| | FI | | | Mounjaro 12.5 mg | 4 | PA | PA | k.A. | | solution pour injection en stylo pré-rempli: Tirzepatidum 12.5mg / 0.5ml | Eli Lilly (Suisse) SA | B | FB | | G |  |